Drug profile

The FDA adverse-event record for Pain Meds (Unknown)

149 adverse-event reports submitted to the FDA Center for Veterinary Medicine reference Pain Meds (Unknown). See the species affected, top reactions, and outcomes below.

149
adverse-event reports
6.7%
death-coded share
Dog
most-reported species
35
Vomiting - top reaction
Verify with FDA CVM →
Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
149
Total Reports
10
Deaths Reported
6.7%
Death Rate

Active Ingredients

Pain Meds (Unknown)

Administration Routes

UnknownOralParenteralOtherIntravenousTopical

Species Affected

Dog 127
Cat 20
Human 2

Most Affected Breeds

Retriever - Labrador 15
Shih Tzu 9
Domestic Shorthair 9
Dachshund (unspecified) 7
Terrier - Yorkshire 7
Crossbred Canine/dog 7
Dog (unknown) 6
Chihuahua 6
Retriever - Golden 5
Pit Bull 5

Most Reported Reactions

Vomiting 35
Emesis 34
Lethargy (see also Central nervous system depression in 'Neurological') 24
Not eating 20
Lack of efficacy - NOS 12
Lethargy (see also Central nervous system depression in Neurological) 11
Lack of efficacy (ectoparasite) - flea 9
Behavioural disorder NOS 9
Diarrhoea 9
Pain NOS 9
Shaking 8
Dehydration 8

Outcome Breakdown

Recovered/Normal
58 (38.9%)
Outcome Unknown
37 (24.8%)
Ongoing
29 (19.5%)
Recovered with Sequela
15 (10.1%)
Euthanized
7 (4.7%)
Died
3 (2.0%)

Pain Meds (Unknown) Adverse Event Insights

149 reports name Pain Meds (Unknown); 10 recorded a death outcome (6.7% of reported events, not a population-level mortality rate). Active ingredient: Pain Meds (Unknown). Administration routes: Unknown, Oral, Parenteral, Other.

By species: Dog (127 reports), Cat (20 reports), Human (2 reports). By breed: Retriever - Labrador (15), Shih Tzu (9), Domestic Shorthair (9).

Leading clinical signs: Vomiting (35), Emesis (34), Lethargy (see also Central nervous system depression in 'Neurological') (24), Not eating (20). Outcome, 149 coded reports: Recovered/Normal leads at 38.9%.

Read these counts as reporting volume, not risk: per our methodology, a widely-prescribed drug will rack up more raw FDA reports in a given year than a rarely-used one at an identical true rate, so we recommend comparing within similar-exposure products rather than across the full 2025 catalog.

Source: FDA Center for Veterinary Medicine openFDA Animal & Veterinary Adverse Events (CVM AER) · 2025

Every figure on PlainBreed is rendered directly from FDA openFDA adverse event data, no number is typed in by an editor. This page draws directly on FDA openFDA data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.